Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?

References

• Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-417618441
   PubMed Web of Science ®Google Scholar
• Chung C, Metser U, Menard C. Advances in magnetic resonance imaging and positron emission tomography imaging for grading and molecular characterization of glioma. Semin Radiat Oncol. 2015;25(3):164–171. doi:10.1016/j.semradonc.2015.02.00226050586
   PubMed Web of Science ®Google Scholar
• Choi YS, Kim DW, Lee SK, et al. The added prognostic value of preoperative dynamic contrast-enhanced MRI histogram analysis in patients with glioblastoma: analysis of overall and progression-free survival. AJNR Am J Neuroradiol. 2015;36(12):2235–2241. doi:10.3174/ajnr.A444926338911
   PubMed Web of Science ®Google Scholar
• Jia ZZ, Gu HM, Zhou XJ, et al. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging. Eur J Radiol. 2015;84(9):1805–1809. doi:10.1016/j.ejrad.2015.05.03526066470
   PubMed Web of Science ®Google Scholar
• Awasthi R, Rathore RK, Soni P, et al. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology. 2012;54(3):205–213. doi:10.1007/s00234-011-0874-y21541688
   PubMed Web of Science ®Google Scholar
• Papamichael D, Audisio RA, Glimelius B, et al. Treatment of colorectal cancer in older patients: international Society of Geriatric Oncology (SIOG) consensus recommendations 2013. Ann Oncol. 2015;26(3):463–476. doi:10.1093/annonc/mdu25325015334
   PubMed Web of Science ®Google Scholar
• Li X, Zhu Y, Kang H, et al. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging. Cancer Imaging. 2015;15:4. doi:10.1186/s40644-015-0039-z25889239
   PubMed Web of Science ®Google Scholar
• Hu YC, Yan LF, Wu L, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: efficacy in preoperative grading. Sci Rep. 2014;4:7208. doi:10.1038/srep0720825434593
   PubMed Web of Science ®Google Scholar
• Cebeci H, Aydin O, Ozturk-Isik E, et al. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method. Eur J Radiol. 2014;83(10):1914–1919. doi:10.1016/j.ejrad.2014.07.00225087109
   PubMed Web of Science ®Google Scholar
• Bisdas S, Koh TS, Roder C, et al. Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results. Neuroradiology. 2013;55(10):1189–1196. doi:10.1007/s00234-013-1229-723852430
   PubMed Web of Science ®Google Scholar
• Nguyen TB, Cron GO, Mercier JF, et al. Preoperative prognostic value of dynamic contrast-enhanced MRI-derived contrast transfer coefficient and plasma volume in patients with cerebral gliomas. AJNR Am J Neuroradiol. 2015;36(1):63–69. doi:10.3174/ajnr.A400624948500
   PubMed Web of Science ®Google Scholar
• Liu ZC, Yan LF, Hu YC, et al. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial. BMC Med Imaging. 2017;17(1):10. doi:10.1186/s12880-017-0183-y28143434
   PubMedGoogle Scholar
• Han Y, Yan LF, Wang XB, et al. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis. BMC Cancer. 2018;18(1):215. doi:10.1186/s12885-018-4114-229467012
   PubMedGoogle Scholar
• Tian Q, Yan LF, Zhang X, et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI. J Magn Reson Imaging. 2018. doi:10.1002/jmri.26010
   Web of Science ®Google Scholar
• Hu YC, Yan LF, Sun Q, et al. Comparison between ultra-high and conventional mono b-value DWI for preoperative glioma grading. Oncotarget. 2017;8(23):37884–37895. doi:10.18632/oncotarget.1418028039453
   PubMedGoogle Scholar
• Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505. doi:10.1148/radiology.168.2.33936713393671
   PubMed Web of Science ®Google Scholar
• Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3(1):1–7. doi:10.1038/jcbfm.1983.16822610
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–232. doi:10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S10508281
   PubMed Web of Science ®Google Scholar
• Bergamino M, Saitta L, Barletta L, et al. Measurement of blood-brain barrier permeability with t1-weighted dynamic contrast-enhanced MRI in brain tumors: a comparative study with two different algorithms. ISRN Neurosci. 2013;2013:905279. doi:10.1155/2013/90527924959569
   PubMedGoogle Scholar
• Tietze A, Mouridsen K, Mikkelsen IK. The impact of reliable prebolus T 1 measurements or a fixed T 1 value in the assessment of glioma patients with dynamic contrast enhancing MRI. Neuroradiology. 2015;57(6):561–572. doi:10.1007/s00234-015-1502-z25744200
   PubMed Web of Science ®Google Scholar
• Wangaryattawanich P, Hatami M, Wang J, et al. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neuro-Oncology. 2015;17(11):1525–1537. doi:10.1093/neuonc/nov11726203066
   PubMed Web of Science ®Google Scholar
• Pichler J, Pachinger C, Pelz M, Kleiser R. MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression–a pilot study. Eur J Radiol. 2013;82(5):e240–245. doi:10.1016/j.ejrad.2012.12.01823399039
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim JH, Kim SH, Cho KG, Kim SY. Posttreatment high-grade glioma: usefulness of peak height position with semiquantitative MR perfusion histogram analysis in an entire contrast-enhanced lesion for predicting volume fraction of recurrence. Radiology. 2010;256(3):906–915. doi:10.1148/radiol.1009146120634429
   PubMed Web of Science ®Google Scholar
• Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI. Korean J Radiol. 2013;14(3):487–492. doi:10.3348/kjr.2013.14.3.48723690718
   PubMed Web of Science ®Google Scholar
• Zhao J, Yang ZY, Luo BN, Yang JY, Chu JP. Quantitative evaluation of diffusion and dynamic contrast-enhanced MR in tumor parenchyma and peritumoral area for distinction of brain tumors. PLoS One. 2015;10(9):e0138573. doi:10.1371/journal.pone.013857326384329
   PubMed Web of Science ®Google Scholar
• Zhang N, Zhang L, Qiu B, Meng L, Wang X, Hou BL. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging. 2012;36(2):355–363. doi:10.1002/jmri.v36.222581762
   PubMed Web of Science ®Google Scholar
• Brendle C, Hempel JM, Schittenhelm J, et al. Glioma grading and determination of IDH mutation status and ATRX loss by DCE and ASL perfusion. Clin Neuroradiol. 2017;28:421–428.28488024
   PubMed Web of Science ®Google Scholar
• Jung SC, Yeom JA, Kim JH, et al. Glioma: application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading. AJNR Am J Neuroradiol. 2014;35(6):1103–1110. doi:10.3174/ajnr.A382524384119
   PubMed Web of Science ®Google Scholar
• Hilario A, Hernandez-Lain A, Sepulveda JM, Lagares A, Perez-Nunez A, Ramos A. Perfusion MRI grading diffuse gliomas: impact of permeability parameters on molecular biomarkers and survival. Neurocirugia (Astur). 2019;30(1):11–18. doi:10.1016/j.neucir.2018.06.00430143443
   PubMed Web of Science ®Google Scholar
• Ulyte A, Katsaros VK, Liouta E, et al. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients. Neuroradiology. 2016;58(12):1197–1208. doi:10.1007/s00234-016-1741-727796446
   PubMed Web of Science ®Google Scholar
• Zinn PO, Colen RR, Kasper EM, Burkhardt JK. Extent of resection and radiotherapy in GBM: a 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. Int J Oncol. 2013;42(3):929–934. doi:10.3892/ijo.2013.177023338774
   PubMed Web of Science ®Google Scholar
• Syed M, Liermann J, Verma V, et al. Survival and recurrence patterns of multifocal glioblastoma after radiation therapy. Cancer Manag Res. 2018;10:4229–4235. doi:10.2147/CMAR.S16595630323678
   PubMed Web of Science ®Google Scholar
• Eseonu CI, Eguia F, ReFaey K, et al. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival. J Neurooncol. 2017;134(1):65–74. doi:10.1007/s11060-017-2486-928527004
   PubMed Web of Science ®Google Scholar
• Almenawer SA, Badhiwala JH, Alhazzani W, et al. Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro-Oncology. 2015;17(6):868–881. doi:10.1093/neuonc/nou34925556920
   PubMed Web of Science ®Google Scholar
• Tang S, Liao J, Long Y. Comparative assessment of the efficacy of gross total versus subtotal total resection in patients with glioma: a meta-analysis. Int J Surg. 2019;63:90–97. doi:10.1016/j.ijsu.2019.02.00430742934
   PubMed Web of Science ®Google Scholar
• Martinez R, Volter C, Behr R. Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time. Br J Neurosurg. 2008;22(4):557–562. doi:10.1080/0268869080216642418686059
   PubMed Web of Science ®Google Scholar
• Patel CK, Vemaraju R, Glasbey J, et al. Trends in peri-operative performance status following resection of high grade glioma and brain metastases: the impact on survival. Clin Neurol Neurosurg. 2018;164:67–71. doi:10.1016/j.clineuro.2017.11.01629197281
   PubMed Web of Science ®Google Scholar
• de Fatima Vasco Aragao M, Law M, Batista de Almeida D, et al. Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas. AJNR Am J Neuroradiol. 2014;35(8):1495–1502. doi:10.3174/ajnr.A390524699088
   PubMed Web of Science ®Google Scholar
• Koob M, Girard N, Ghattas B, et al. The diagnostic accuracy of multiparametric MRI to determine pediatric brain tumor grades and types. J Neurooncol. 2016;127(2):345–353. doi:10.1007/s11060-015-2042-426732081
   PubMed Web of Science ®Google Scholar
• Wang XC, Zhang H, Tan Y, et al. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas. J Magn Reson Imaging. 2014;39(6):1569–1574. doi:10.1002/jmri.2431224987755
   PubMed Web of Science ®Google Scholar
• Fudaba H, Shimomura T, Abe T, et al. Comparison of multiple parameters obtained on 3T pulsed arterial spin-labeling, diffusion tensor imaging, and MRS and the Ki-67 labeling index in evaluating glioma grading. AJNR Am J Neuroradiol. 2014;35(11):2091–2098. doi:10.3174/ajnr.A401824994829
   PubMed Web of Science ®Google Scholar
• Dunet V, Maeder P, Nicod-Lalonde M, et al. Combination of MRI and dynamic FET PET for initial glioma grading. Nuklearmedizin. 2014;53(4):155–161. doi:10.3413/Nukmed-0650-14-0324737132
   PubMedGoogle Scholar
• Goda JS, Dutta D, Raut N, et al. Can multiparametric MRI and FDG-PET predict outcome in diffuse brainstem glioma? A report from a prospective phase-II study. Pediatr Neurosurg. 2013;49(5):274–281. doi:10.1159/00036616725277867
   PubMed Web of Science ®Google Scholar
• Liang J, Liu D, Gao P, et al. Diagnostic values of DCE-MRI and DSC-MRI for differentiation between high-grade and low-grade gliomas: a comprehensive meta-analysis. Acad Radiol. 2018;25(3):338–348. doi:10.1016/j.acra.2017.10.00129223713
   PubMed Web of Science ®Google Scholar
• Anzalone N, Castellano A, Cadioli M, et al. Brain gliomas: multicenter standardized assessment of dynamic contrast-enhanced and dynamic susceptibility contrast MR images. Radiology. 2018;287(3):933–943. doi:10.1148/radiol.201717036229361245
   PubMed Web of Science ®Google Scholar